# Safety and Feasibility of an Endotoxemia Model

> **NCT01329965** · PHASE1 · COMPLETED · sponsor: **Penn State University** · enrollment: 6 (actual)

## Conditions studied

- Cardiovascular Disease
- Inflammation

## Interventions

- **DRUG:** LPS (reference endotoxin, E. coli O113:H10:K:neg, manufactured under GMP)

## Key facts

- **NCT ID:** NCT01329965
- **Lead sponsor:** Penn State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329965, "Safety and Feasibility of an Endotoxemia Model". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01329965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*